Background: Fibrosis in ulcerative colitis has remained largely unexplored despite
| INTRODUCTION
Fibrosis is a common complication of chronic inflammation and can affect all organs and tissues. 1 In the intestine, fibrosis is a wellrecognised complication of Crohn's disease, leading to clinically relevant intestinal strictures in at least one-third of patients throughout their disease course. 2, 3 In Crohn's disease, strictures are predominantly located in the terminal ileum, but are far less common in the colon (around 8%). 4 Very little attention has been devoted to fibrosis in other forms of chronic intestinal inflammation such as ulcerative colitis. In this form of inflammatory bowel disease, colonic stricture formation also occurs, with strictures ranging from 1% to 11.2%, the large majority of which are benign. [5] [6] [7] [8] Fibrosis in the ulcerative colitis colorectal wall may have significant clinical implications, such as colonic motility abnormalities, 9, 10 possibly leading to important symptoms such as loose stools, diarrhoea, abdominal discomfort, pain and anorectal dysfunction, or may present as rectal urgency and incontinence associated with a decreased compliance of the rectal wall. [11] [12] [13] These clinical symptoms can occur in the absence of obvious macroscopic or microscopic inflammation and an apparently normal mucosa, and may be frequently misclassified as irritable bowel syndrome. 14, 15 Fibrosis is defined as an excessive accumulation of extracellular matrix (ECM) and an expansion of the mesenchymal cell pool, and both components are likely to be present in chronic intestinal inflammation-associated strictures, including in ulcerative colitis. The muscularis mucosae in the area of ulcerative colitis strictures are markedly thickened, while the other intestinal layers are not different compared to nonstrictured areas of ulcerative colitis or normal colon. 16 Some studies have described excessive ECM deposition, mainly in the submucosa, as a significant component of stricturing ulcerative colitis. 17 Surprisingly, few reports of ulcerative colitis-associated fibrosis outside of the area of strictures are available. [18] [19] [20] [21] These reports, however, are based on the evaluation of single tissue sections per patient, often comparing distinct colonic locations in different patients, which limit their value in regard to learning about the real frequency and degree of severity of localised fibrosis. Until today, data on global assessment of the extent of fibrosis along the colon length, the overall fibrotic burden, and its correlation with clinical features are missing. Nevertheless, these data may be critical to establish an association with clinical phenotypes, and this study was designed to fill this knowledge gap.
| MATERIALS AND METHODS

| Patient population
Eighty-nine consecutive ulcerative colitis patients who underwent total colectomy or proctocolectomy at the Cleveland Clinic in 2007
were included. The diagnosis of ulcerative colitis was based on clinical, radiographic, endoscopic and histopathological criteria, and confirmed according to the European Crohn's and Colitis Organization (ECCO) clinical consensus guidelines. 22 Patient demographics and clinical characteristics are shown in (29.9) colectomy for Crohn's colitis, 10 patients who underwent sigmoid resection for diverticular disease, and 10 patients who underwent colectomy for colorectal cancer. In the latter patient group, sections were obtained at least 2 cm from the neoplastic area in macroscopically and histologically normal colon tissue. The diagnosis of Crohn's disease was made based on clinical, radiographic, endoscopic and histopathological criteria as summarised in the ECCO clinical consensus guidelines. 23 The diagnosis of diverticular disease was based on pathological assessment, and clinical and radiographic data.
Clinical data including age at diagnosis, disease duration at colec- of Sirius red was examined under polarised light to determine the amount of collagen in the tissue, as previously described. 24 
| Grading of inflammation
Inflammation was graded based on the Geboes score 25 and we separated histological features of chronic mucosal injury and active inflammation. This is consistent with current standard pathology terminology for ulcerative colitis 26 and is also reflected in the latest ECCO clinical consensus on Ulcerative colitis. 22 The numerical
Geboes score was determined as previously described 27 26 and is also reflected in the latest ECCO clinical consensus on ulcerative colitis. 22 The classification is depicted in Figure 1 .
| Assessment of fibrosis
Fibrosis was assessed qualitatively and quantitatively in each section.
Quantitative assessment was performed using calibrated imaging software (CellSens, Olympus Corporation, Tokyo, Japan). Specific measurements of the intestinal layers were determined on haematoxylin and eosin-stained sections and included a full-thickness measurement, as well as a measurement of each histologic bowel wall layer (mucosa, muscularis mucosae, submucosa, muscularis propria interna, muscularis propria externa and complete muscularis propria).
These measurements were performed in two planes per slide, corresponding to the most and least submucosa present (maximum and minimum submucosal thickness; Figure 2 ). Qualitative assessment was performed by an experienced gastrointestinal pathologist (IOG) taking into account all of the tissue on the slide. Lamina propria fibrosis was categorised as present or absent, regardless of extent.
Submucosal fibrosis was categorised as none, 1%-25%, 26%-50%, 51%-75%, or 76%-100% of the submucosa affected, corresponding to a fibrosis score of 0, 1, 2, 3 and 4, respectively. The "fibrosis burden score" was defined as the average fibrosis score across all the involved segments. The fibrosis burden score was calculated per patient. As control, the same fibrosis burden score was calculated for the non-involved segments. To illustrate the method, we included Table S1 .
| Interobserver variability
Three gastrointestinal pathologists reviewed all well-oriented haematoxylin and eosin-and Masson trichrome-stained sections of colonic resections of ulcerative colitis (n = 50) with varying degrees of fibrosis and from the comparison groups including Crohn's disease (n = 10), diverticular disease (n = 10) and non-neoplastic segments from colon carcinoma (n = 10) resections. After review of a learning set with examples from different cases, sections for the study were assessed for presence or absence of lamina propria fibrosis and qualitative extent of submucosal fibrosis, using methods as described in "Assessment of fibrosis" above.
| Comparison of Trichrome and Sirius red staining
To assign the pathologist's assessment of fibrosis to an objective measurement, the above described 80 (50 + 10 + 10 + 10)
sections stained for Sirius red were scanned, and the percent surface area positive for Sirius red under polarised light was automatically quantified by ImagePro software (Media Cybernetics, Rockville, MD). The obtained percentages of submucosa covered by matrix were rescaled to match the pathologists' assessment range from 0% to 100%, as described in the section "Assessment of fibrosis", using the formula: 100 9 ((ValueÀMinimum)/(MaximumÀMinimum)).
(A) (B)
F I G U R E 2 Measurement method for whole thickness intestinal cross-sections. Specific measurements were determined on haematoxylinand eosin-stained sections and included a full-thickness measurement, as well as a measurement of each histological intestinal wall layer (mucosa, muscularis mucosae, submucosa, muscularis propria). These measurements were performed in two areas per slide, corresponding to the highest (A) and lowest (B) thickness of submucosa present. Arrow colours: black-full thickness; blue-muscularis propria; green-submucosa; red-mucosa Severely active X.4 n/a n/a n/a n/a n/a Ulcer or granulation tissue
Severely active submucosal fibrosis percent by using Jonckheere-Terpstra test. Presence of any fibrosis in the mucosa was compared using McNemar's test. Area of fibrosis was determined using Wilcoxon rank sum test.
Biopsy results vs degree of fibrosis in the cross-sections: Generalised estimating equations (GEE) were used to assess associations between the various features measured from biopsy samples and area of fibrosis modelled as the outcome using a cumulative logit link function. In addition, linear mixed models were used to assess relationship between the various features measured from biopsy samples and muscularis mucosae thickness measured from resection samples. To assess agreement between biopsy and resection findings, we assumed independence between segments and used McNemar's test to assess agreement for binary findings and Wilcoxon signed rank test. A P < 0.05 was considered statistically significant. All analyses were performed using SAS (Version 9.4, The SAS Institute, Cary, NC).
3 | RESULTS
| Clinical phenotypes of the population
A total of 89 ulcerative colitis subjects (48.3% female and 96.6%
Caucasian) were included in the final analysis ( These results suggest that submucosal and lamina propria fibrosis can be adequately assessed using haematoxylin and eosin, and that a "fibrosis-specific" stain, such as Masson trichrome, does not appreciably improve the detection and quantification of fibrosis in ulcerative colitis. (Table S2) Fibrosis burden was compared in 24 patients who had both involved and non-involved colonic segments, and found that fibrosis burden was significantly higher in the involved areas (P < 0.001), and this was true for haematoxylin and eosin and Masson trichrome stain (Table 3 ; Figure 4B ). In addition, the thickness of the muscularis mucosae was markedly higher in the involved compared to the noninvolved segments (142.8 vs 48.6 lm; P < 0.001). In the 24 patients who had both involved and non-involved segments, muscularis mucosae thickness was also significantly higher in involved areas (P < 0.001; Table 3 ; Figure 4C ,E). The same was true for the thickness of the lamina propria (P < 0.001, data not shown), but not the other layers of the intestinal wall, leading to an overall increase in wall thickness. We additionally constructed longitudinal plots to show variation in the degree of fibrosis assessing only the inflamed areas along the colon ( Figure 4D ,E). The degree of fibrosis increased from the proximal to distal segments (P < 0.001), and a comparable pattern was found for the thickness of the muscularis mucosae (P = 0.075; Figure 4D ,E).
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A so-called "lead pipe colon" has been described in chronic ulcerative colitis, indicating a shortened and stiff colon by radiological or endoscopic findings 32 that could be related to the amount of fibrosis or thickness of the muscularis mucosae in the organ. To account for anatomic and surgical variation, we evaluated the proctocolectomy specimens separately. There was no significant correlation between the specimen length and the fibrosis burden measured by haematoxylin and eosin in involved (rho = À011; P = 0.53) or non-involved areas (rho = 0.02; P = 0.98). The fibrosis burden measured by Masson trichrome was higher but still did not significantly correlate with colon length. A significant correlation was also absent between length of colectomy specimen and average muscularis mucosae thickness in involved or non-involved areas.
| Chronic mucosal injury, but not active inflammation is linked to fibrosis in ulcerative colitis
To evaluate if active inflammation or chronic mucosal injury, defined as stated in Section 2, influences the degree of fibrosis, we separated each segment into no inflammation, active inflammation only, chronic mucosal injury only and active inflammation plus chronic mucosal injury at the same time ( Figure 5 ). There was a clear association (P < 0.001), with no inflammation having the lowest and chronic mucosal injury plus active inflammation having the highest degree of fibrosis. Comparable results were obtained when investigating the muscularis mucosae with the greatest thickness in patients with active inflammation and chronic mucosal injury at the same time ( Figure 5 ).
As a control, we additionally measured the thickness of all other layers of the intestinal wall. The overall wall thickness was highest in the segments with active inflammation plus chronic mucosal injury and this increase was mainly driven by an increased thickness of the lamina propria and muscularis mucosae (data not shown).
After accounting for multiple segments per patient, fibrosis burden and muscularis mucosae thickness were both found to be associated with the numerical total Geboes score. For every unit increase in the haematoxylin and eosin fibrosis score, the Geboes score increased an average of 2.2 points (95% CI 1.9, 2.4; P < 0.001). Similarly, for every unit increase in Masson trichrome fibrosis score, the Geboes score increased an average of 1.9 points (95% CI 1.7, 2.2; P < 0.001). For every 100 lm increase in the muscularis mucosae thickness, the Geboes score increased an average of 0.22 points (95% CI 0.015, 0.43; P = 0.034; Figure 6 ). Among all immune cells present in the inflamed mucosa, in particular eosinophils have been reported to be linked to fibrosis of several organs. 
51%-75% 76%-100%
Eosinophils in the lamina propria, analysed separately using Geboes
Grade 2A criteria, were not linked to the degree of fibrosis in ulcerative colitis (data not shown).
| Overall fibrosis burden and clinical characteristics
Clinical characteristics could influence the degree of fibrosis in ulcerative colitis. We investigated an association between clinical characteristics, medication intake and the overall fibrosis burden (Table 4) . (Table 4) . We also performed a subgroup analysis in patients with refractory disease only. In this subgroup, none of the examined clinical parameters were associated with the fibrotic burden on Masson trichrome and only male gender conferred a higher risk for fibrosis on haematoxylin and eosin (Table 5) .
Based on the above data, thickening of the muscularis mucosae seems to be a hallmark of fibrosis in ulcerative colitis. We therefore linked the prior tested clinical characteristics to the average thickness of the muscularis mucosae in the involved areas. Considering all patients, the longer the disease duration, the thicker was the muscularis mucosae (Table 6) , and pre-operative biological use was associated with a reduced thickness of the muscularis mucosae. In the subgroup of patients with refractory disease, only duration of antitumour necrosis factor use was linked to a thinner muscularis mucosae (Table 6 ).
| Comparative assessment of fibrosis in endoscopic mucosal biopsies and resected specimens
We next assessed whether findings in endoscopic mucosal biopsies reflect the presence and degree of submucosal fibrosis detected using surgically resected specimens. For this purpose, ulcerative colitis subjects undergoing colonoscopy with endoscopic mucosal biopsies taken <4 weeks prior to colectomy were selected. The location of the biopsies was recorded and the same exact location was used to assess fibrosis in the corresponding resected specimen. A total of 39 segments from 21 patients (demographics described in Table 2 ) were included in the analysis (average of 2 AE 1 segments per patient). Neither the presence of lamina propria fibrosis nor morphology of the muscularis mucosae (uniformly thickened, split or splayed) on biopsy findings corresponded with submucosal fibrosis. Accordingly, the thickness of the muscularis mucosae in the biopsies was not linked to the amount of submucosal fibrosis in the corresponding resection specimen (data not shown). Next, biopsies were graded for the Geboes scores. There was no association between the Geboes scores in the biopsy and the underlying degree of fibrosis (P = 0.14) or the thickness of the muscularis mucosae (P = 0.29). Taken together, these data indicate that there were no features on the endoscopic biopsies corresponding with features of fibrosis in ulcerative colitis resections.
| Comparison of fibrosis in ulcerative colitis, Crohn's disease, diverticular disease and controls
We compared the degree of submucosal fibrosis in ulcerative colitis with control colonic segments derived from Crohn's colitis, diverticular disease and non-neoplastic areas of resections for colorectal cancer. All specimens were selected from corresponding anatomical colonic segments ( Table 7 ). The Geboes score was highest in ulcerative colitis and Crohn's disease compared to diverticular disease and normal colon, and there was no significant difference in regard to the presence or grade of lamina propria or submucosal fibrosis between Ulcerative colitis, Crohn's disease and diverticular disease as measured by the percent of submucosa affected by fibrosis. There was also no significant difference in the thickness of the lamina propria, muscularis mucosae or submucosa among all four groups, with 
| DISCUSSION
This manuscript characterises a long-neglected problem of fibrosis complicating Ulcerative colitis. Multiple lines of evidence indicate that colonic strictures occur in ulcerative colitis with frequencies that range from 1% to 11.2%. [5] [6] [7] [8] Using strict criteria (ie, difficulty in passing the endoscope or a >50% reduction of the colonic lumen) strictures were found in 1.5% of patients. 34 While there is a justified concern about the risk of malignancy, most colonic strictures in ulcerative colitis are benign, 4, 6, 17 strongly suggesting that fibrosis is the leading cause of these strictures. An increase in the thickness of the muscularis mucosae, but not the submucosa, and increased fibrosis in the submucosa was noted when looking at single cross-sections per patient. (Table S2) . By including consecutive segments of colon for each ulcerative colitis patient, we were able to identify involved and noninvolved segments within each subject. anti-tumour necrosis factor use was associated with a thinner muscularis mucosae. This may suggest that inflammation control has an effect on remodelling of the intestinal wall. However, these findings may be confounded by the fact that patients with more severe disease are more likely to receive immunomodulators or biologics.
To our surprise, neither the degree of fibrosis nor the degree of muscularis mucosae thickening was linked to shortening of the colon. This stands against the intuitive belief that fibrosis may induce a reduced colonic length despite an absence of objective data. Future studies need to address non-invasive means to quantify and monitor fibrosis in ulcerative colitis to be able to connect histopathological findings to clinical presentation and to allow using ulcerative colitis as a model to test novel anti-fibrotics in the future.
It has to be mentioned that at this time no method is available that allows the non-invasive determination of bowel fibrosis with high accuracy. A prospective study is underway linking clinical symptoms, wall compliance and histopathology at time of colectomy in ulcerative colitis. In summary, the results of this study suggest that ulcerative colitis is a condition associated with progressive fibrosis and muscularis mucosae thickening. The degree of fibrosis and muscularis mucosae thickening is linked to the severity and chronicity of inflammation.
Data from Crohn's disease stricturoplasties indicate reversibility of fibrosis 36 and a case report of reversal of a benign rectal stricture suggests this could also be the case in ulcerative colitis, 37 underscoring the dynamic nature of fibrosis in inflammatory bowel disease.
Given the serious clinical implications, this field is in critical need of further studies to characterise, diagnose and treat fibrosis in ulcerative colitis. Significantly different from CD. 3 Significantly different from diverticular disease. 4 Significantly different from Normal.
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